The DOI matches its Crossref record; 410 of the 410 references it cites were found in a registry or an index.
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 410
A tightly associated serine/threonine protein kinase regulates phosphoinositide 3-kinase activity.
Carpenter, C. L., Auger, K. R., Duckworth, B. C., Hou, W. M., Schaffhausen, B., & Cantley, L. C. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.3.1657 · Cited by 206
Serine/threonine phosphorylation in cytokine signal transduction
McCubrey, J., May, W. S., Duronio, V, & Mufson, A. (2000) · Leukemia · doi:10.1038/sj.leu.2401657 · Cited by 206
Self-citationSTAT signaling in the pathogenesis and treatment of leukemias
Lin, T. S., Mahajan, S., & Frank, D. A. (2000) · Oncogene · doi:10.1038/sj.onc.1203486 · Cited by 205
Bayés, M., Rabasseda, X., & Prous, J. (2002) · PubMed · Cited by 200
Liu, Y., & Rohrschneider, L. R. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02425-0 · Cited by 199
Loda, M. F., Capodieci, P., Mishra, R., Yao, H. W., Corless, C. L., Grigioni, W. F., Wang, Y., Magi-Galluzzi, C., & Stork, P. A. (1996) · Europe PMC (PubMed Central) · Cited by 195
Seger, R., Seger, D., Lozeman, F. J., Ahn, N. G., Graves, L. M., Campbell, J. S., Ericsson, L., Harrylock, M., Jensen, A. M., & Krebs, E. G. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35648-5 · Cited by 195
RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML)
Flotho, C., Valcamonica, S., Mach-Pascual, S., Schmahl, G., Corral, L., Ritterbach, J., Hasle, H., Aricò, M., Biondi, A., & Niemeyer, C. (1999) · Leukemia · doi:10.1038/sj.leu.2401240 · Cited by 194
Winston, L. A., & Hunter, T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.52.30837 · Cited by 192
Cellular Response to Oncogenic Ras Involves Induction of the Cdk4 and Cdk6 Inhibitor p15INK4b
Malumbres, M., de Castro, I. P., Hernández, M. I., Jiménez, M., Corral, T., & Pellicer, À. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2915-2925.2000 · Cited by 191
Xiao, A., Wu, H., Pandolfi, P. P., Louis, D. N., & Van Dyke, T. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00029-6 · Cited by 188
Beltman, J., McCormick, F., & Cook, S. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.43.27018 · Cited by 186
Knobbe, C. B., Merlo, A., & Reifenberger, G. (2002) · Neuro-Oncology · doi:10.1093/neuonc/4.3.196 · Cited by 186
Cyclic AMP Inhibits Akt Activity by Blocking the Membrane Localization of PDK1
Kim, S., Jee, K., Kim, D., Koh, H., & Chung, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m001492200 · Cited by 185
Zhou, X.-P., Loukola, A., Salovaara, R., Nystrom-Lahti, M., Peltomäki, P., de la Chapelle, A., Aaltonen, L. A., & Eng, C. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64200-9 · Cited by 185
Neshat, M. S., Raitano, A. B., Wang, H.-G., Reed, J. C., & Sawyers, C. L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1179-1186.2000 · Cited by 185
Taylor, V., Wong, M., Brandts, C., Reilly, L., Dean, N. M., Cowsert, L. M., Moodie, S., & Stokoe, D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.18.6860-6871.2000 · Cited by 183
Protein kinase C inhibitors as novel anticancer drugs
Jirousek, M. R., & Goekjian, P. G. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.12.2117 · Cited by 182
Untying the regulation of the Raf-1 kinase
Dhillon, A. S., & Kolch, W. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00244-8 · Cited by 180
The v-Src SH3 domain binds phosphatidylinositol 3'-kinase.
Liu, X., Marengere, L. E., Koch, C. A., & Pawson, T. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.9.5225 · Cited by 178
Structure, expression and chromosomal mapping of c-akt: relationship to v-akt and its implications.
Bellacosa, A., Franke, T. F., González, M. E., Datta, K., Taguchi, T., Gardner, J., Cheng, J. Q., Testa, J. R., & Tsichlis, P. N. (1993) · PubMed · Cited by 176
Prasad, K. V., Janssen, O., Kapeller, R., Raab, M., Cantley, L. C., & Rudd, C. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.7366 · Cited by 170
Stępczyńska, A., Lauber, K., Engels, I. H., Janßen, O., Kabelitz, D., Wesselborg, S., & Schulze‐Osthoff, K. (2001) · Oncogene · doi:10.1038/sj.onc.1204221 · Cited by 167
The Mouse B-raf Gene Encodes Multiple Protein Isoforms with Tissue-specific Expression
Barnier, J. V., Papin, C., Eychène, A., Lecoq, O., & Calothy, G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23381 · Cited by 166
Enrichment of hematopoietic precursor cells and cloning of multipotential B-lymphocyte precursors.
McKearn, J. P., McCubrey, J., & Fagg, B. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.21.7414 · Cited by 164
Self-citationMinamoto, S., Ikegame, K., Ueno, K., Narazaki, M., Naka, T., Yamamoto, H., Matsumoto, T., Saito, H., Hosoe, S., & Kishimoto, T. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7080 · Cited by 164
Stephens, L., Eguinoa, A., Corey, S., Jackson, T., & Hawkins, P. T. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05880.x · Cited by 162
Differentiation of 3T3-L1 Fibroblasts to Adipocytes Induced by Transfection of ras Oncogenes
Benito, M., Porras, A., Nebreda, A. R., & Santos, E. (1991) · Science · doi:10.1126/science.1857988 · Cited by 161
JAK-STAT signaling activated by Abl oncogenes
Danial, N. N., & Rothman, P. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203484 · Cited by 161
Velazquez, L., Mogensen, K. E., Barbieri, G., Fellous, M., Uzé, G., & Pellegrini, S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.7.3327 · Cited by 161
Gaemers, I. C., Vos, H. L., Volders, H. H., van der Valk, S. W., & Hilkens, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009449200 · Cited by 161
Ahmed, N. N., Franke, T. F., Bellacosa, A., Datta, K., Gonzalez-Portal, M. E., Taguchi, T., Testa, J. R., & Tsichlis, P. N. (1993) · PubMed · Cited by 160
A genome-based strategy uncovers frequent BRAF mutations in melanoma
Pollock, P. M., & Meltzer, P. S. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00089-2 · Cited by 160
Negative regulation of PI 3‐kinase by Ruk, a novel adaptor protein
Gout, I. T., Middleton, G., Adu, J., Ninkina, N. N., Дробот, Л. Б., Filonenko, V., Matsuka, G., Davies, A. M., Waterfield, M. D., & Buchman, V. L. (2000) · The EMBO Journal · doi:10.1093/emboj/19.15.4015 · Cited by 160
Fan, S., Ma, Y. X., Wang, J.-A., Yuan, R.-Q., Meng, Q., Cao, Y., Laterra, J. J., Goldberg, I. D., & Rosen, E. M. (2000) · Oncogene · doi:10.1038/sj.onc.1203566 · Cited by 159
Pritchard, C. A., Bolin, L., Slattery, R., Murray, R., & McMahon, M. (1996) · Current Biology · doi:10.1016/s0960-9822(02)00548-1 · Cited by 159
Identification of two SH3-binding motifs in the regulatory subunit of phosphatidylinositol 3-kinase.
Kapeller, R., Prasad, K. V., Janßen, O., Hou, W.-S., Schaffhausen, B. S., Rudd, C. E., & Cantley, L. C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42115-6 · Cited by 158
Blalock, W., Weinstein-Oppenheimer, C., Chang, F., Hoyle, P., Wang, X.-Y., Algate, P., Franklin, R., Oberhaus, S., Steelman, L., & McCubrey, J. (1999) · Leukemia · doi:10.1038/sj.leu.2401493 · Cited by 158
Self-citationOwa, T., Yoshino, H., Yoshimatsu, K., & Nagasu, T. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013371996 · Cited by 158
Kinases: positive and negative regulators of apoptosis
Franklin, R. A., & McCubrey, J. A. (2000) · Leukemia · doi:10.1038/sj.leu.2401967 · Cited by 158
Self-citationQuon, M. J., Chen, H., Ing, B. L., Liu, M.-L., Zarnowski, M. J., Yonezawa, K., Kasuga, M., Cushman, S. W., & Taylor, S. I. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5403 · Cited by 157
Fujitani, Y., Hibi, M., Fukada, T., Takahashi-Tezuka, M., Yoshida, H., Yamaguchi, T., Sugiyama, K., Yamanaka, Y., Nakajima, K., & Hirano, T. (1997) · Oncogene · doi:10.1038/sj.onc.1200907 · Cited by 156
Andreeff, M., Jiang, S., Zhang, X., Konopleva, M. Y., Estrov, Z. E., Snell, V., Xie, Z., Okcu, M., Sanchez‐Williams, G., Dong, J., et al. (1999) · Leukemia · doi:10.1038/sj.leu.2401573 · Cited by 153
Klippel, A., Escobedo, J. A., Hirano, T., & Williams, L. T. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.4.2675 · Cited by 149
Hindley, A. D., & Kölch, W. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.8.1575 · Cited by 147
Knobbe-Thomsen, C. B. (2002) · Neuro-Oncology · doi:10.1215/15228517-4-3-196 · Cited by 146
MacDougall, L. K., Domin, J., & Waterfield, M. D. (1995) · Current Biology · doi:10.1016/s0960-9822(95)00278-8 · Cited by 145
Soltoff, S. P., & Cantley, L. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.1.563 · Cited by 143
Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells
Penard‐Lacronique, V., Boureux, A., Monni, R., Dumon, S., Mauchauffé, M., Mayeux, P., Gouilleux, F., Berger, R., Gisselbrecht, S., Ghysdael, J., et al. (2000) · Blood · doi:10.1182/blood.v95.6.2076 · Cited by 140
Altiok, S., Batt, D. B., Altıok, N., Papautsky, A., Downward, J., Roberts, T. M., & Avraham, H. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32274 · Cited by 139
Erhardt, P., Troppmair, J., Rapp, U. R., & Cooper, G. M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5524 · Cited by 139
Morgan, M. A., Dolp, O., & Reuter, C. W. (2001) · Blood · doi:10.1182/blood.v97.6.1823 · Cited by 137
Tian, S., Tapley, P., Sincich, C., Stein, R., Rosen, J., & Lamb, P. (1996) · Blood · doi:10.1182/blood.v88.12.4435.bloodjournal88124435 · Cited by 136
Yao, R., & Cooper, G. M. (1996) · PubMed · Cited by 135
Hunt, J. T., Ding, C. Z., Batorsky, R. S., Bednarz, M. S., Bhide, R. S., Cho, Y. H., Chong, S., Chao, S. T., Gullo-Brown, J. L., Guo, P., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000248z · Cited by 135
Constitutive activation of JAK–STAT3 signaling by BRCA1 in human prostate cancer cells
Gao, B., Shen, X., Kunos, G., Meng, Q., Goldberg, I. D., Rosen, E. M., & Fan, S. (2001) · FEBS Letters · doi:10.1016/s0014-5793(00)02430-3 · Cited by 133
Rescue of cells from ras oncogene-induced growth arrest by a second, complementing, oncogene.
Hirakawa, T., & Ruley, H. E. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.5.1519 · Cited by 133
3'-phosphoinositide-dependent kinase-1 (PDK-1) in PI 3-kinase signaling
Störz, P., & Toker, A. (2002) · Frontiers in bioscience · doi:10.2741/storz · Cited by 131
Interleukin-3 receptor in acute leukemia
Testa, U., Riccioni, R., Diverio, D., Rossini, A., Coco, F. L., & Peschle, C. (2003) · Leukemia · doi:10.1038/sj.leu.2403224 · Cited by 131
Biochemical and biological analysis of Mek1 phosphorylation site mutants.
Huang, W., Kessler, D. S., & Erikson, R. L. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.3.237 · Cited by 131
Activated Ras displaces 14-3-3 protein from the amino terminus of c-Raf-1.
Rommel, C., Radziwill, G., Lovrić, J., Noeldeke, J., Heinicke, T., Jones, D., Aitken, A., & Moelling, K. (1996) · PubMed · Cited by 131
Matallanas, D., Arozarena, I., Berciano, M. T., Aaronson, D. S., Pellicer, À., Lafarga, M., & Crespo, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209807200 · Cited by 130
Rheb is in a high activation state and inhibits B-Raf kinase in mammalian cells
Im, E., von Lintig, F. C., Chen, J. L., Zhuang, S., Qui, W., Chowdhury, S., Worley, P. F., Boss, G. R., & Pilz, R. B. (2002) · Oncogene · doi:10.1038/sj.onc.1205792 · Cited by 130
Palmer, R. H., Dekker, L. V., Woscholski, R., Good, J. A. L., Gigg, R., & Parker, P. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.38.22412 · Cited by 129
Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia
Luo, J.-M., Yoshida, H., Komura, S., Ohishi, N., Pan, L., Shigeno, K., Hanamura, I., Miura, K., Iida, S., Ueda, R., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2402725 · Cited by 127
Fernandes, A. M., Hamburger, A. W., & Gerwin, B. I. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991112)83:4<564::aid-ijc20>3.0.co;2-q · Cited by 126
Sattler, M., Verma, S., Byrne, C. H., Shrikhande, G., Winkler, T., Algate, P. A., Rohrschneider, L. R., & Griffin, J. D. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.11.7473 · Cited by 126
Pagès, G., Brunet, A., L’Allemain, G., & Pouysségur, J. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06599.x · Cited by 125
Oakes, S. A., Candotti, F., Johnston, J. A., Chen, Y., RYAN, J., Taylor, N. N., Liu, X., Hennighausen, L. G., Notarangelo, L. D., Paul, W. E., et al. (1996) · Immunity · doi:10.1016/s1074-7613(00)80274-5 · Cited by 125
Miwa, W., Yasuda, J., Murakami, Y., Yashima, K., Sugano, K., Sekine, T., Kono, A., Egawa, S., Yamaguchi, K. D., Hayashizaki, Y., et al. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1280 · Cited by 123
Watanabe, S., Itoh, T., & Arai, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.21.12681 · Cited by 121
Carter, A. B., & Hunninghake, G. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003599200 · Cited by 119
Senderowicz, A. M. (2002) · The Oncologist · doi:10.1634/theoncologist.7-suppl_3-12 · Cited by 119
Comparison of potential markers of farnesyltransferase inhibition.
Adjei, A. A., Davis, J. N., Erlichman, C., Svingen, P. A., & Kaufmann, S. H. (2000) · PubMed · Cited by 119
Park, J., Strock, C. J., Ball, D. W., & Nelkin, B. D. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.543-554.2003 · Cited by 119
Musacchio, A., Cantley, L. C., & Harrison, S. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14373 · Cited by 117
Regulation of the Raf-1 kinase domain by phosphorylation and 14-3-3 association
Yip-Schneider, M., Miao, W., Amy, L. I. N., Barnard, D., Tzivion, G., & Marshall, M. S. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3510151 · Cited by 116
Salomoni, P., Wasik, M. A., Riedel, R. F., Reiss, K., Choi, J. K., Skórski, T., & Calabretta, B. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.1995 · Cited by 116
Chromosome and Molecular Abnormalities in Myelodysplastic Syndromes
Fenaux, P. (2001) · International Journal of Hematology · doi:10.1007/bf02994004 · Cited by 114
A novel cAMP-stimulated pathway in protein phosphatase 2A activation.
Feschenko, M., Stevenson, E., Nairn, A., & Sweadner, K. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.111 · Cited by 114
Autocrine-mediated Activation of STAT3 Correlates with Cell Proliferation in Breast Carcinoma Lines
Li, L., & Shaw, P. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109962200 · Cited by 113
Current status of clinical trials of farnesyltransferase inhibitors
Karp, J. E., Kaufmann, S. H., Adjei, A. A., Lancet, J. E., Wright, J. J., & End, D. W. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200111000-00009 · Cited by 112
Fusion of the ets Transcription Factor TEL to Jak2 Results in Constitutive Jak-Stat Signaling
Ho, J. M.-Y., Beattie, B. K., Squire, J. A., Frank, D. A., & Barber, D. L. (1999) · Blood · doi:10.1182/blood.v93.12.4354 · Cited by 111
McCubrey, J. A., Steelman, L., Hoyle, P., Blalock, W. L., Oppenheimer, C. W., Franklin, R. A., Cherwinski, H. M., Bosch, E., & McMahon, M. (1998) · Leukemia · doi:10.1038/sj.leu.2401215 · Cited by 110
Self-citationMEN2A-RET-induced cellular transformation by activation of STAT3
Schuringa, J. J., Wojtachnio, K., Hagens, W. I., Vellenga, E., Buys, C. H. C. M., Hofstra, R. M. W., & Kruijer, W. (2001) · Oncogene · doi:10.1038/sj.onc.1204715 · Cited by 109
Protein Kinase A as Target for Novel Integrated Strategies of Cancer Therapy
Tortora, G., & Ciardiello, F. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04332.x · Cited by 109
Cytoplasmic localization of the mitogen-activated protein kinase activator MEK.
Zheng, C. F., & Guan, K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32112-9 · Cited by 104
Klippel, A., Escobedo, J. A., Hu, Q., & Williams, L. T. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.9.5560 · Cited by 104
Sturgill, T. W., & Ray, L. B. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(86)80457-0 · Cited by 104
An, W. G., Schnur, R. C., Neckers, L., & Blagosklonny, M. V. (1997) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050626 · Cited by 104
Chang, J., Metcalf, D., Lang, R., Gonda, T., & Johnson, G. (1989) · Blood · doi:10.1182/blood.v73.6.1487.1487 · Cited by 104
Serum- and Glucocorticoid-inducible Kinase SGK Phosphorylates and Negatively Regulates B-Raf
Zhang, B.-H., Tang, E., Zhu, T., Greenberg, M. E., Vojtek, A. B., & Guan, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102808200 · Cited by 103
Muraille, É., Pesesse, X., KUNTZ, C., & Erneux, C. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3420697 · Cited by 103
Structural and functional diversity of phosphoinositide 3-kinases
Zvelebil, M., MacDougall, L. K., Leevers, S. J., Volinia, S., Vanhaesebroeck, B., Gout, I. T., Panayotou, G., Domin, J., Stein, R. C., Pagès, F., et al. (1996) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1996.0019 · Cited by 102
Constitutive Activation of STAT5 by a Point Mutation in the SH2 Domain
Ariyoshi, K., Nosaka, T., Yamada, K., Onishi, M., Oka, Y., Miyajima, A., & Kitamura, T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909771199 · Cited by 101
Lindeman, G. J., Wittlin, S., Lada, H., Naylor, M. J., Santamaria, M., Zhang, J., Starr, R., Hilton, D. J., Alexander, W. S., Ormandy, C. J., et al. (2001) · Genes & Development · doi:10.1101/gad.880801 · Cited by 101
Direct Association of Grb2 with the p85 Subunit of Phosphatidylinositol 3-Kinase
Wang, J., Auger, K. R., Jarvis, L. A., Shi, Y., & Roberts, T. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.21.12774 · Cited by 100
Loss of p21WAF1/CIP1 accelerates Ras oncogenesis in a transgenic/knockout mammary cancer model
Adnane, J., Jackson, R. J., Nicosia, S. V., Cantor, A. B., Pledger, W. J., & Sebti, S. M. (2000) · Oncogene · doi:10.1038/sj.onc.1203956 · Cited by 100
Feldkamp, M. M., Lau, N. C., Roncari, L., & Guha, A. (2001) · PubMed · Cited by 100
STOYANOVA, S., Bulgarelli-Leva, G., Kirsch, C., Hanck, T., Klinger, R., Wetzker, R., & Wymann, M. P. (1997) · Biochemical Journal · doi:10.1042/bj3240489 · Cited by 99
Thymic lymphoma induction by the AKT8 murine retrovirus.
Staal, S. P., & Hartley, J. W. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.167.3.1259 · Cited by 99
Briones, N. J., Malcolm, K. C., Nick, J. A., & Worthen, G. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204455200 · Cited by 97
Dimitroff, C. J., Klohs, W. D., Sharma, A., Pera, P. J., Driscoll, D. L., Veith, J. M., Steinkampf, R. W., Schroeder, M. C., Klutchko, S. R., Sumlin, A. B., et al. (1999) · Investigational New Drugs · doi:10.1023/a:1006367032156 · Cited by 96
Panek, R. L., Lu, G. H., Klutchko, S. R., Batley, B. L., Dahring, T. K., Hamby, J. M., Hallak, H., Doherty, A. M., & Keiser, J. A. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37140-x · Cited by 96
Holt, K. H., Olson, A. L., Moye-Rowley, S., & Pessin, J. E. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.42-49.1994 · Cited by 95
Tanuma, N., Nakamura, K., Shima, H., & Kikuchi, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003661200 · Cited by 95
STAT3 activation is required for Asp816 mutant c-Kit induced tumorigenicity
Ning, Z.-Q., Li, J., McGuinness, M., & Arceci, R. J. (2001) · Oncogene · doi:10.1038/sj.onc.1204590 · Cited by 94
Mitogenic signaling of Ras is regulated by differential interaction with Raf isozymes
Weber, C. K., Slupsky, J. R., Herrmann, C., Schuler, M., Rapp, U. R., & Block, C. (2000) · Oncogene · doi:10.1038/sj.onc.1203261 · Cited by 90
Therapeutic targeting of Src-kinase Lyn in myeloid leukemic cell growth
Roginskaya, V. Y., Zuo, S., Caudell, E. G., Nambudiri, G., Kraker, A. J., & Corey, S. (1999) · Leukemia · doi:10.1038/sj.leu.2401429 · Cited by 90
Hoyle, P., Moye, P. W., Steelman, L., Blalock, W. L., Franklin, R. A., Pearce, M., Cherwinski, H. M., Bosch, E., McMahon, M., & McCubrey, J. A. (2000) · Leukemia · doi:10.1038/sj.leu.2401720 · Cited by 89
Self-citationSwannie, H., & Kaye, S. B. (2002) · Current Oncology Reports · doi:10.1007/s11912-002-0046-7 · Cited by 89
Pathways for phosphoinositide synthesis
Tolias, K. F., & Cantley, L. C. (1999) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(99)00019-5 · Cited by 88
Constitutive Association of c-N-Ras with c-Raf-1 and Protein Kinase Cε in Latent Signaling Modules
Hamilton, M., Liao, J., Cathcart, M. K., & Wolfman, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102001200 · Cited by 88
Oncogenic transformation of cells by a conditionally active form of the protein kinase Akt/PKB.
Mirza, A. M., Kohn, A. D., Roth, R. A., & McMahon, M. (2000) · PubMed · Cited by 87
The role of Jak3 in lymphoid development, activation, and signaling
Thomis, D. C., & Berg, L. J. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80108-2 · Cited by 87
MEK, ERK, and p90RSK are present on mitotic tubulin in Swiss 3T3 cells
Willard, F. S., & Crouch, M. F. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(01)00185-1 · Cited by 86
Aberrant hematopoiesis in mice with inactivation of the gene encoding SOCS-1
Metcalf, D., Alexander, W., Elefanty, A., Nicola, N., Hilton, D., Starr, R., Mifsud, S., & di Rago, L. (1999) · Leukemia · doi:10.1038/sj.leu.2401440 · Cited by 84
Developmentally-regulated expression of murine K-ras isoforms
Pells, S., Divjak, M., Romanowski, P., Impey, H., Hawkins, N. J., Clarke, A. R., Hooper, M. L., & Williamson, D. J. (1997) · Oncogene · doi:10.1038/sj.onc.1201354 · Cited by 83
Ferby, I., Waga, I., Hoshino, M., Kume, K., & Shimizu, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.20.11684 · Cited by 81
Gα and Gβγ Require Distinct Src-dependent Pathways to Activate Rap1 and Ras
Schmitt, J., & Stork, P. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204006200 · Cited by 80
Leslie, N. R., Alex, G. R. A. Y., Pass, I., Orchiston, E. A., & Downes, C. P. (2000) · Biochemical Journal · doi:10.1042/bj3460827 · Cited by 80
Cyclic AMP Blocks Cell Growth through Raf-1-Dependent and Raf-1-Independent Mechanisms
Dumaz, N., Light, Y., & Marais, R. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3717-3728.2002 · Cited by 78
Liu, R. Y., Fan, C. L., Garcia, R., Jove, R., & Zuckerman, K. S. (1999) · Blood · doi:10.1182/blood.v93.7.2369 · Cited by 76
Tan, C., Mui, A., & Dedhar, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108673200 · Cited by 76
Mutations in the ABL kinase domain pre-exist the onset of imatinib treatment
Roche‐Lestienne, C., & Preudhomme, C. (2003) · Seminars in Hematology · doi:10.1016/s0037-1963(03)70025-0 · Cited by 75
Cytogenetic and molecular mechanisms of resistance to imatinib
Hochhaus, A. (2003) · Seminars in Hematology · doi:10.1053/shem.2003.50045 · Cited by 75
Isoform-Specific Localization of A-RAF in Mitochondria
Yuryev, A., Ono, M., Goff, S. A., Macaluso, F., & Wennogle, L. P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.13.4870-4878.2000 · Cited by 75
Synergism of v- myc and v-Ha- ras in the in Vitro Neoplastic Progression of Murine Lymphoid Cells
Schwartz, R. C., Stanton, L. W., Riley, S. C., Marcu, K. B., & Witte, O. N. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.9.3221 · Cited by 75
Blalock, W. L., Pearce, M., Steelman, L. S., Franklin, R. A., McCarthy, S. A., Cherwinski, H. M., McMahon, M., & McCubrey, J. A. (2000) · Oncogene · doi:10.1038/sj.onc.1203337 · Cited by 75
Self-citationItoh, T., Liu, R., Yokota, T., Arai, K., & Watanabe, S. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.742 · Cited by 74
Bosch, E., Cherwinski, H. M., Peterson, D., & McMahon, M. (1997) · Oncogene · doi:10.1038/sj.onc.1201270 · Cited by 74
Cloning and characterization of a novel class II phosphoinositide 3-kinase containing C2 domain.
Misawa, H., Ohtsubo, M., Copeland, N., Gilbert, D. J., Jenkins, N., & Yoshimura, A. (1998) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1006/bbrc.1998.8294 · Cited by 73
Uncoupling Raf1 from MEK1/2 Impairs Only a Subset of Cellular Responses to Raf Activation
Pearson, G. W., Bumeister, R., Henry, D. O., Cobb, M. H., & White, M. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000570200 · Cited by 72
A Phosphatidylinositol 3-Kinase-dependent Pathway That Differentially Regulates c-Raf and A-Raf
Sutor, S. L., Vroman, B. T., Armstrong, E. A., Abraham, R. T., & Karnitz, L. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.11.7002 · Cited by 72
The AKT1 proto-oncogene maps to human chromosome 14, band q32
Staal, S. P., Huebner, K., Croce, C. M., Parsa, N. Z., & Testa, J. R. (1988) · Genomics · doi:10.1016/0888-7543(88)90114-0 · Cited by 72
Demoulin, J., Uyttenhove, C., Lejeune, D., Mui, A., Groner, B., & Renauld, J. (2000) · PubMed · Cited by 72
von Willebrand, M., Jascur, T. A., Bonnefoy, N., Yano, H., Altman, A., Matsuda, Y., & Mustelin, T. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00828.x · Cited by 68
C-RAF-1 serine/threonine kinase is required in BCR/ABL-dependent and normal hematopoiesis.
Skórski, T., Nieborowska-Skorska, M., Szczylik, C. A., Kanakaraj, P., Perrotti, D., Zon, G., Gewirtz, A. M., PERUSSIA, B., & Calabretta, B. (1995) · PubMed · Cited by 66
Jak2-Stat5 Interactions Analyzed in Yeast
Barahmand-Pour, F., Meinke, A. L., Groner, B., & Decker, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.12567 · Cited by 64
Liao, Y., Satoh, T., Gao, X., Jin, T. J., Hu, C., & Kataoka, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101737200 · Cited by 63
ERK signalling and oncogene transformation are not impaired in cells lacking A-Raf
Mercer, K., Chiloeches, A., Hüser, M., Kiernan, M., Marais, R., & Pritchard, C. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205101 · Cited by 63
McCubrey, J. A., Lee, J. T., Steelman, L. S., Blalock, W. L., Moye, P. W., Chang, F., Pearce, M., Shelton, J. G., White, M. K., Franklin, R. A., et al. (2001) · PubMed · Cited by 62
Self-citationIntegrin-linked kinase, a promising cancer therapeutic target: biochemical and biological properties
Yoganathan, N., Yee, A., Zhang, Z., Leung, D., Yan, J., Fazli, L., Kojic, D. L., Costello, P., Jabali, M., Dedhar, S., et al. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00192-4 · Cited by 61
Cloning and nucleotide sequence of the murine interleukin‐3 gene
Campbell, H. D., Ymer, S., Fung, M. C., & Young, I. G. (1985) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1985.tb09020.x · Cited by 60
An Essential Role for Src Kinase in ErbB Receptor Signaling through the MAPK Pathway
Olayioye, M. A., Badache, A., Daly, J. M., & Hynes, N. E. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5242 · Cited by 57
Genomic Sequence, Organization, and Chromosomal Localization of HumanJAK3
Riedy, M. C., Dutra, A. S., Blake, T. B., Modi, W. S., Lal, B. K., Davis, J., Bosse, A., O’Shea, J. J., & Johnston, J. A. (1996) · Genomics · doi:10.1006/geno.1996.0520 · Cited by 57
Blalock, W. L., Navolanic, P. M., Steelman, L. S., Shelton, J. G., Moye, P. W., Lee, J. T., Franklin, R. A., Mirza, A. M., McMahon, M., White, M. K., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2402925 · Cited by 56
Self-citationGeldanamycin decreases Raf‐1 and Akt levels and induces apoptosis in neuroblastomas
Kim, S., Kang, J., Hu, W., Evers, B. M., & Chung, D. H. (2002) · International Journal of Cancer · doi:10.1002/ijc.10820 · Cited by 54
Kamiguti, A. S., Harris, R. J., Slupsky, J. R., Baker, P. K., Cawley, J. C., & Zuzel, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206398 · Cited by 54
Mek1 Phosphorylation Site Mutants Activate Raf-1 in NIH 3T3 Cells
Alessandrini, A., Greulich, H. E., Huang, W., & Erikson, R. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31612 · Cited by 54
The Requirement of Specific Membrane Domains for Raf-1 Phosphorylation and Activation
Carey, K. D., Watson, R. T., Pessin, J. E., & Stork, P. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207014200 · Cited by 53
Inhorn, R. C., Carlesso, N., Durstin, M., Frank, D. A., & Griffin, J. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8665 · Cited by 50
Shelton, J. G., Moye, P. W., Steelman, L. S., Blalock, W. L., Lee, J. T., Franklin, R. A., McMahon, M., & McCubrey, J. A. (2003) · Leukemia · doi:10.1038/sj.leu.2403052 · Cited by 49
Self-citationGarcia, L., Garcia, F., Llorens, F., Unzeta, M., Itarte, E., & Gómez, N. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02950-2 · Cited by 49
Blalock, W. L., Moye, P. W., Chang, F., Pearce, M., Steelman, L., McMahon, M., & McCubrey, J. A. (2000) · Leukemia · doi:10.1038/sj.leu.2401793 · Cited by 49
Self-citationHunter, S., Koch, B. L., & Anderson, S. M. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.9.9980 · Cited by 48
Microtubule Integrity Regulates Pak Leading to Ras-independent Activation of Raf-1
Zang, M., Waelde, C. A., Xiang, X., Rana, A., Wen, R., & Luo, Z. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100152200 · Cited by 48
Doyle, S. E., & Gasson, J. C. (1998) · Blood · doi:10.1182/blood.v92.3.867 · Cited by 46
Eng, C. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04337.x · Cited by 44
High Bcr-Abl expression prevents the translocation of Bax and Bad to the mitochondrion
Keeshan, K., Cotter, T. G., & McKenna, S. L. (2002) · Leukemia · doi:10.1038/sj.leu.2402576 · Cited by 44
Therapeutic efficacy of prenylation inhibitors in the treatment of myeloid leukemia
Morgan, M. A., Ganser, A., & Reuter, C. W. (2003) · Leukemia · doi:10.1038/sj.leu.2403024 · Cited by 44
Synergy between Raf and BCL2 in abrogating the cytokine dependency of hematopoietic cells
Moye, P. W., Blalock, W. L., Hoyle, P., Chang, F., Franklin, R. A., Oppenheimer, C. W., Pearce, M., Steelman, L. S., McMahon, M., & McCubrey, J. A. (2000) · Leukemia · doi:10.1038/sj.leu.2401792 · Cited by 43
Self-citationMcCubrey, J. A., Holland, G. D., McKearn, J. P., & Risser, R. (1989) · PubMed · Cited by 43
Self-citationNosaka, T., & Kitamura, T. (2000) · PubMed · Cited by 39
Differentiation and malignant transformation: Two roads diverged in a wood
Baserga, R., & Morrione, A. (1999) · Journal of Cellular Biochemistry · Cited by 39
Morgan, M. A., Wegner, J., Aydilek, E., Ganser, A., & Reuter, C. W. (2003) · Leukemia · doi:10.1038/sj.leu.2403022 · Cited by 39
Phosphoinositide 3-kinase knockout mice: role of p85α in B cell development and proliferation
Fruman, D. A., Snapper, S. B., Yballe, C. M., Alt, F. W., & Cantley, L. C. (1999) · Biochemical Society Transactions · doi:10.1042/bst0270624 · Cited by 38
Gu, J., Wang, Y., & Gu, X. (2002) · Journal of Molecular Evolution · doi:10.1007/s00239-001-0072-3 · Cited by 37
Oncogenic effects of overexpression of the interleukin-3 receptor on hematopoietic cells.
Steelman, L., Algate, P. A., Blalock, W. L., Wang, X. Y., PREVOST, K., Hoyle, P., & McCubrey, J. A. (1996) · PubMed · Cited by 37
Self-citationInterleukin-11 Receptor Expression in Primary Ovarian Carcinomas
Campbell, C. L., Guardiani, R., Ollari, C., Nelson, B. E., Quesenberry, P. J., & Savarese, T. M. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2000.6064 · Cited by 36
Effects of inducible MEK1 activation on the cytokine dependency of lymphoid cells
Blalock, W. L., Pearce, M., Chang, F., Lee, J. T., Pohnert, S. C., Burrows, C., Steelman, L., Franklin, R. A., McMahon, M., & McCubrey, J. A. (2001) · Leukemia · doi:10.1038/sj.leu.2402109 · Cited by 36
Self-citationA novel germline mutation of PTEN associated with brain tumours of multiple lineages
Staal, F. J. T., van der Luijt, R. B., Baert, M. R. M., van Drunen, J., van Bakel, H., Peters, E. D. J., de Valk, I., van Amstel, H. K. P., TAPHOORN, M. J. B., Jansen, G. H., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600206 · Cited by 35
Identification of a latent MAP kinase kinase kinase in PC12 cells as B‐raf
Traverse, S., & Cohen, P. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00723-3 · Cited by 35
Banholzer, R., Nair, A. P. K., Hirsch, H. H., Ming, X., & Moroni, C. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.6.3254 · Cited by 35
Clinical development of farnesyltransferase inhibitors in leukemias and myelodysplastic syndrome
Kurzrock, R., Cortes, J. E., & Kantarjian, H. M. (2002) · Seminars in Hematology · doi:10.1053/shem.2002.36925 · Cited by 34
Cytogenetic and molecular heterogeneity of 7q36/12p13 rearrangements in childhood AML
Simmons, H., Oseth, L., Nguyen, P. L., O’Leary, M., Conklin, K., & Hirsch, B. A. (2002) · Leukemia · doi:10.1038/sj.leu.2402773 · Cited by 34
Lee, J. T., & McCubrey, J. A. (2002) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.6.6.659 · Cited by 33
Self-citationSignaling Via the Interferon-α Receptor in Chronic Myelogenous Leukemia Cells
Verma, A., & Platanias, L. C. (2002) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190290016782 · Cited by 33
Signalling via phosphoinositide 30H kinases
Hawkins, P. T., Welch, H. C. E., McGregor, A., Eguinoa, A., Gobert, S., Krugmann, S., Anderson, K. E., Stokoe, D., & Stephens, L. (1997) · Biochemical Society Transactions · doi:10.1042/bst0251147 · Cited by 33
Gale, R. E., Freeburn, R. W., Khwaja, A., Chopra, R., & Linch, D. C. (1998) · Blood · doi:10.1182/blood.v91.1.54 · Cited by 32
Mesquita, D. D. D., Zhan, Q., Crossley, L. J., & Badwey, J. A. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02669-2 · Cited by 32
Genetic profile, PTEN mutation and therapeutic role of PTEN in glioblastomas
Fan, X., Aalto, Y., Sanko, S., Knuutila, S., Klatzmann, D., & Castresana, J. S. (2002) · International Journal of Oncology · doi:10.3892/ijo.21.5.1141 · Cited by 32
Scheele, J. S., Räpple, D., & Lübbert, M. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000675 · Cited by 31
Raf-induced transformation requires an interleukin 1 autocrine loop.
Vale, T., Ngo, T.-T. B., White, M. A., & Lipsky, P. E. (2001) · PubMed · Cited by 31
Hannemann, J., Hara, T., Kawai, M., Miyajima, A., Ostertag, W., & Stocking, C. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2402 · Cited by 30
Cell Cycle Checkpoints and Cancer
Bártek, J. (2002) · Leukemia · doi:10.1038/sj.leu.2402380 · Cited by 30
Novel targeted therapies for Bcr–Abl positive acute leukemias: beyond STI571
Nimmanapalli, R., & Bhalla, K. N. (2002) · Oncogene · doi:10.1038/sj.onc.1206086 · Cited by 30
Freitas, F., Jeschke, M. G., Majstorović, I., Mueller, D. R., Schindler, P. A., Voshol, H., van Oostrum, J., & Šuša, M. (2002) · Bone · doi:10.1016/s8756-3282(01)00625-1 · Cited by 29
RAS Signalling Is Abnormal in a c- raf1 MEK1 Double Mutant
Bottorff, D. A., Stang, S. L., Agellon, S., & Stone, J. C. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.9.5113 · Cited by 29
UCN-01 induces cytotoxicity toward human CLL cells through a p53-independent mechanism
Byrd, J. C., Shinn, C. A., Willis, C. R., Flinn, I. W., Lehman, T., Sausville, E. A., Lucas, D. M., & Grever, M. R. (2001) · Experimental Hematology · doi:10.1016/s0301-472x(01)00649-x · Cited by 27
Wang, X. Y., Steelman, L. S., & McCubrey, J. A. (1997) · PubMed · Cited by 27
Self-citationEffects of deregulated RAF and MEK1 expression on the cytokine-dependency of hematopoietic cells
McCubrey, J. A., Steelman, L. S., Moye, P. W., Hoyle, P., Oppenheimer, C. W., Chang, F., Pearce, M., White, M. K., Franklin, R. A., & Blalock, W. L. (2000) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(99)00033-3 · Cited by 26
Self-citationBcl-2 determines susceptibility to induction of lung cancer by oncogenic CRaf.
Fedorov, L. M., Tyrsin, O. Y., Papadopoulos, T., Camarero, G., Götz, R., & Rapp, U. R. (2002) · PubMed · Cited by 26
REGULATION OF THE Raf KINASE BY PHOSPHORYLATION
Zhang, B., & Guan, K. (2001) · Experimental Lung Research · doi:10.1080/019021401300054046 · Cited by 25
Targeting oncogene dependence and resistance
Hingorani, S. R., & Tuveson, D. A. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00115-6 · Cited by 24
Lu, D., Nounou, R., Beran, M., Estey, E., Manshouri, T., Kantarjian, H., Keating, M. J., & Albitar, M. (2003) · Cancer · doi:10.1002/cncr.11037 · Cited by 23
Mazet, J., Padieu, M., Osman‐Ponchet, H., Maume, G., Mailliet, P., Dereu, N. L. M., Hamilton, A. D., Lavelle, F., Sebti, S. M., & Maume, B. F. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01355-1 · Cited by 23
Miralem, T., & Avraham, H. K. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.579-593.2003 · Cited by 22
Mayo, M., Wang, X., Algate, P. A., Arana, G., Hoyle, P., Steelman, L., & McCubrey, J. A. (1995) · Blood · doi:10.1182/blood.v86.8.3139.3139 · Cited by 21
Self-citationGenomic organization of human JAK2 and mutation analysis of its JH2-domain in leukemia
Cools, J., Peeters, P. J., Voet, T., Aventin, A. M., Mecucci, C., Grandchamp, B., & Marynen, P. (1999) · Cytogenetic and Genome Research · doi:10.1159/000015308 · Cited by 20
Cited by
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
McCubrey, J. A., Steelman, L. S., Chappell, W. H., Abrams, S. L., Wong, E. W. T., Chang, F., Lehmann, B., Terrian, D. M., Milella, M., Tafuri, A., et al. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.10.001 · Cited by 2,284
Self-citationMechanisms and functional significance of tumour-induced dendritic-cell defects
Gabrilovich, D. (2004) · Nature Reviews Immunology · doi:10.1038/nri1498 · Cited by 1,024
FDA-approved small-molecule kinase inhibitors
Wu, P., Nielsen, T. E., & Clausen, M. H. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.04.005 · Cited by 1,013
The role of IL-6 and STAT3 in inflammation and cancer
Hodge, D. R., Hurt, E. M., & Farrar, W. L. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.016 · Cited by 950
Hochhaus, A., O'Brien, S. G., Guilhot, F., Druker, B. J., Branford, S., Foroni, L., Goldman, J. M., Müller, M. C., Radich, J. P., Rudoltz, M., et al. (2009) · Leukemia · doi:10.1038/leu.2009.38 · Cited by 856
Metadata
- Authors
- Steelman, L. S., Pohnert, S. C., Shelton, J. G., Franklin, R. A., Bertrand, F. E., & McCubrey, J. A.
- Venue
- Leukemia
- Published
- 2004-01-22
- Volume
- 18
- Issue
- 2
- Pages
- 189-218
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W1529003705
- Cited by
- 684
- References
- 410
- FWCI
- 22.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.